Consequently, the therapeutic implications of targeted therapy against both VEGF and VEGFR2 may be significant in the management of gastric cancer.
← all excerpts
An Overview of Current Biomarkers, the Therapeutic Implications, and the Emerging Role of hERG1 Expression in Gastric Cancer: A Literature Review.
1
—
—